A R T I C L E S
O’Sullivan et al.
1H), 3.57 (dd, J ) 10.5, 4.2 Hz, 1H), 2.94 (dd, J ) 13.5, 6.4 Hz, 1H),
2.81 (dd, J ) 13.5, 2.3 Hz, 1H), 2.09 (s, 3H), 1.94-1.65 (m, 5H),
1.03 (d, J ) 7.0 Hz, 3H), 1.00 (d, J ) 7.1 Hz, 3H); 13C NMR (100
MHz, CDCl3) δ 171.3, 170.8, 78.9, 73.3, 64.1, 39.8, 36.3, 35.5, 31.7,
21.0, 13.4, 1.0; IR (film) 3454 (OH), 1720 (CO) cm-1; MS (CI, NH3)
m/z (rel intensity) 259 [20, (M + H)+]; HRMS (CI, NH3) m/z 259.1545
(259.1546 calcd for C13H23O5 MH). Anal. Calcd for C13H22O5: C, 60.5;
H, 8.6. Found: C, 60.6; H, 8.6.
10.9, -4.2, -4.6; IR (film) 3467 (OH), 1742 (CO) cm-1; MS (CI,
NH3) m/z (rel intensity) 516 [15, (M + NH4)+], 499 [18, (M + H)+];
HRMS (CI, NH3) m/z 499.3445 (499.3455 calcd for C27H51O6Si, MH).
4(R),5(S),8(S)-4-Acetoxy-8-[(E),1(S),6(S)-6-(tert-butyl-dimethyl-
siloxy)-1,3,7-trimethyl-2-oxo-oct-3-enyl]-5-methyl-oxocan-2-one 58.
To a solution of 57b (11.2 mg, 22.5 µmol) in CH2Cl2 (2 mL) was
added the Dess Martin periodinane (38 mg, 90 µmol). The mixture
was stirred at ambient temperature for 3 h. The solvent was exchanged
with EtOAc, and the reagent was removed by passing the mixture
through a short plug of silica, eluting with EtOAc. The crude product
was purified by column chromatography (hexane/ethyl acetate, 3:1) to
furnish the title compound 58 (9.5 mg, 77%) as a colorless oil; Rf 0.25
4(R),5(S),8(S)-4-Acetoxy-5-methyl-8-[(S)-1-methyl-2-oxoethyl]-
oxocan-2-one, 41. To a solution of 40 (12.0 mg, 46 µmol) in CH2Cl2
(3 mL) was added the Dess Martin periodinane (67 mg, 160 µmol).
After 2 h at ambient temperature, wet CH2Cl2 (1 mL) was added and
the mixture was stirred another 30 min. The solvent was exchanged
with EtOAc by careful evaporation, and the insoluble Dess Martin
reagent was filtered off by quickly passing the mixture through a short
wide plug of Florisil (EtOAc/hexane, 3:1) giving the crude title
compound 41 (12 mg, 46 µmol, 100%). The unstable aldehyde 41 was
used in the next step without further purification; Rf (EtOAc/hexane,
7:3) 0.4; 1H NMR (400 MHz, CDCl3) δ 9.72 (d, J ) 1.2 Hz, 1H), 5.06
(d, J ) 6.1 Hz, 1H), 4.70 (ddd, J ) 13.5, 7.5, 3.4 Hz, 1H), 3.00 (dd,
J ) 13.5, 6.6 Hz, 1H), 2.87 (dd, J ) 13.5, 1.9 Hz, 1H), 2.78 (dqn, J
) 1.2, 7.5 Hz, 1H), 2.10 (s, 3H), 1.94-1.52 (m, 5H), 1.15 (d, J ) 7.5
Hz, 3H), 1.00 (d, J ) 6.6 Hz, 3H).
22
1
(hexane/ethyl acetate, 3:1); [R]D -95.8 (c 0.36, CDCl3); H NMR
(400 MHz, CDCl3) δ 6.76 (t, J ) 6.6 Hz, 1H), 5.07 (d, J ) 5.7 Hz,
1H), 4.79 (ddd, J ) 12.0, 9.1, 2.9 Hz, 1H), 3.63 (td, J ) 6.0, 5.0 Hz,
1H), 3.48 (m, 1H), 2.98 (dd, J ) 13.6, 2.2 Hz, 1H), 2.92 (dd, J )
13.7, 6.0 Hz, 1H), 2.45-2.31 (m, 2H), 2.09 (s, 3H), 1.94-1.64 (m,
5H), 1.77 (s, 3H), 1.05 (d, J ) 2.1 Hz, 3H), 1.03 (d, J ) 1.8 Hz, 3H),
0.90 (m, 12H), 0.89 (s, 3H), 0.06 (s, 6H); 13C NMR (100 MHz, CDCl3)
δ 203.0, 170.7, 170.5, 141.2, 136.8, 78.6, 77.2, 75.8, 73.1, 44.5, 36.4,
35.5, 33.6, 33.3, 31.9, 25.8, 24.0, 21.7, 20.9, 18.1, 17.9, 15.1, 11.9,
-4.3, -4.5; IR (film) 1732 (CO), 1665 (CO) cm-1; MS (CI, NH3) m/z
(rel intensity) 514 [4, (M + NH4)+], 497 [6, (M + H)+]; HRMS (CI,
NH3) m/z 497.3297 (497.3298 calcd for C27H49O6Si, MH).
4(R),5(S),8(S)-4-Acetoxy-8-[(E),1(R),2(R),6(S)-6-(tert-butyldimeth-
ylsilyloxy)-2-hydroxy-1,3,7-trimethyl-oct-3-enyl]-5-methyl-oxocan-
2-one 57a and 4(R),5(S),8(S)-4-Acetoxy-8-[(E),1(R),2(S),6(S)-6-(tert-
butyldimethylsilyloxy)-2-hydroxy-1,3,7-trimethyl-oct-3-enyl]-5-methyl-
oxocan-2-one 57b. The aldehyde 41 (8.0 mg, 0.031 mmol) was
azeotropically evaporated twice with toluene (2 × 2 mL) and dried
under high vacuum in a Schlenk flask prior to use. DMSO (1 mL) was
added via syringe followed by the vinyl iodide 56a (44.9 mg, 0.122
mmol) as a solution in DMSO via cannula (0.5 mL, 0.5 mL rinse). A
mixture of 1% NiCl2 in CrCl2 (38.1 mg, 0.31 mmol) was preweighed
in a glovebox and added to the reaction mixture under a stream of
argon. The dark green solution was stirred at ambient temperature with
the exclusion of light for 24 h, after which time the reaction mixture
was quenched with saturated aqueous ammonium chloride solution (8
mL) and extracted with EtOAc (5 × 10 mL). The combined organic
layers were washed with brine (10 mL) and dried (Na2SO4). Concentra-
tion in vacuo was followed by flash chromatography (ethyl acetate/
hexane, 1:4) to provide the diastereomeric allylic alcohols 57a (9.0
mg, 0.018 mmol, 58%) and 57b (5.1 mg, 0.010 mmol, 33%) as clear
4(R),5(S),8(S)-4-Acetoxy-8-[(E),1(S),6(S)-6-hydroxy-1,3,7-trimethyl-
2-oxo-oct-3-enyl]-5-methyl-oxocan-2-one 55. Crushed glass (150 mg)
was added to a solution of 58 (6.3 mg, 12.6 µmol) in THF (2.0 mL) at
0 °C followed by anhydrous pyridine (300 µL) and 70% HF‚pyridine
(150 µL). The cooling bath was removed, and the mixture was stirred
for 48 h at ambient temperature with additional HF‚pyridine (100 µL)
being added after 24 h. The mixture was filtered through a short wide
plug of silica (EtOAc). Evaporation was followed by flash chroma-
tography (hexane/ethyl acetate, 1:1) to give the title compound 55 (3.8
mg, 9.9 µmol, 80%) as a clear colorless oil; Rf 0.21 (hexane/ethyl
acetate, 1:1); [R]D -126.6 (c 0.29, CH2Cl2); H NMR (400 MHz,
CDCl3) δ 6.87 (t, J ) 7.1 Hz, 1H), 5.05 (brs, 1H), 4.72 (ddd, J 12.2,
9.3, 3.0 Hz, 1H), 3.59-3.50 (m, 2H), 2.95-2.89 (m, 2H), 2.48-2.32
(m, 2H), 2.09 (s, 3H), 1.90-1.67 (m, 7H), 1.35-1.27 (m, 3H), 1.05
(d, J ) 5.5 Hz, 3H), 1.04 (d, J ) 5.2 Hz, 3H), 0.97 (d, J ) 3.6 Hz,
3H), 0.95 (d, J ) 3.7 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 203.3,
170.7, 141.5, 137.5, 79.1, 75.9, 73.0, 44.4, 36.4, 35.5, 34.0, 33.9, 32.0,
30.9, 29.7, 24.0, 21.7, 21.0, 18.7, 17.4, 15.0, 11.8; IR (film) 3468 (OH),
1731 (CO), 1661 (CO) cm-1; MS (FAB) m/z (rel intensity) 383 [50,
(M + H)+]; HRMS (CI, NH3) m/z 383.2435 (383.2434 calcd for
C21H35O6, MH).
22
1
20
colorless oils. Data for 57a: Rf 0.3 (hexane/ethyl acetate, 3:1); [R]D
-27.6 (c 0.25, CHCl3); 1H NMR (400 MHz, CDCl3) δ 5.47 (t, J ) 6.9
Hz, 1H), 5.05 (d, J ) 5.4 Hz, 1H), 4.48-4.44 (m, 1H), 4.28 (s, 1H),
3.49 (m, 1H), 2.95 (dd, J ) 13.5, 6.2 Hz, 1H), 2.87 (d, J ) 13.5 Hz,
1H), 2.20 (m, 2H), 2.11 (s, 3H), 1.95-1.86 (m, 2H), 1.84-1.62 (m,
5H), 1.38 (s, 1H), 1.32-1.22 (m, 3H), 1.04 (d, J ) 7.0 Hz, 3H), 0.89
(s, 9H), 0.87 (d, J ) 7.0 Hz, 3H), 0.85 (d, J ) 7.0 Hz, 3H), 0.76 (d,
J ) 7.0 Hz, 3H), 0.04 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 171.3,
170.8, 136.8, 120.8, 79.2, 77.0, 73.9, 73.3, 40.0, 36.5, 35.6, 32.8, 32.5,
32.3, 25.9, 24.5, 21.3, 21.0, 18.9, 18.1, 17.1, 14.1, 8.8, -4.2, -4.6; IR
(film) 3477 (OH), 1731 (CO) cm-1; MS (CI, NH3) m/z (rel intensity)
516 [40, (M + NH4)+], 499 [8, (M + H)+]; HRMS (CI, NH3) m/z
516.3712 (516.3720 calcd for C27H54O6NSi, MNH4). Anal. Calcd for
C27H50O6Si: C, 65.0; H, 10.1. Found: C, 64.9; H, 10.0.
4(R),5(S),8(S)-4-Hydroxy-8-[(E),1(S),6(S)-6-hydroxy-1,3,7-tri-
methyl-2-oxo-oct-3-enyl]-5-methyl-oxocan-2-one, (-)-Octalactin B,
2. To a solution of 55 (2.8 mg, 7.3 µmol) in 10% DMF/pH 7 buffer
(2.0 mL) was added type VII lipase from Candida cylindracea (Fluka;
35.3 mg). The flask was sealed, and the mixture was excluded from
light and stirred at ambient temperature for a period of 6 d, adding 13
mg, 9.0 mg, 13 mg, 5 mg of enzyme on days 2, 3, 4, and 5, respectively.
Water was added to the mixture, and the aqueous layer was extracted
with Et2O (5 × 10 mL). The combined organic layers were washed
with brine (20 mL), dried (MgSO4), and filtered. The eluent was passed
through a short wide plug of silica (Et2O). Concentration of the eluent
was followed by flash chromatography (ethyl acetate/hexane, 3:1) and
PTLC to give the title natural product (-)-octalactin B, 2 (2.4 mg, 7.0
µmol, 96%), as an oil; Rf 0.15 (hexane/ethyl acetate, 1:2); [R]D24 -123
(c 0.04, CDCl3) {lit.3 [R]D -126}; 1H NMR (400 MHz, CDCl3) δ 6.86
(t, J ) 7.0 Hz, 1H), 4.75 (t, J ) 10.7 Hz, 1H), 4.03 (brs, 1H), 3.56-
3.51 (m, 2H), 3.05 (dd, J ) 13.3, 1.5 Hz, 1H), 2.72 (dd, J ) 13.3, 6.5
Hz, 1H), 2.45 (m, 1H), 2.35 (m, 1H), 1.96 (d, J ) 4.8 Hz, 1H), 1.81-
1.74 (m, 2H), 1.78 (s, 3H), 1.73-1.68 (m, 3H), 1.24-1.18 (m, 1H),
1.14 (d, J ) 7.1 Hz, 3H), 1.05 (d, J ) 7.2 Hz, 3H), 0.98 (d, J ) 6.6
Hz, 3H), 0.96 (d, J ) 6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ
22
Data for 57b: Rf 0.13 (ethyl acetate/hexane, 1:3); [R]D -49.2 (c
1
0.6, CH2Cl2); H NMR (400 MHz, CDCl3) δ 5.42 (dd, J ) 7.0, 0.5
Hz, 1H), 5.04 (d, J ) 6.0 Hz, 1H), 4.80 (dt, J ) 12.3, 3.9 Hz, 1H),
3.76 (dd, J ) 8.7, 2.1 Hz, 1H), 3.48 (dt, J ) 4.4, 5.9 Hz, 1H), 2.98
(dd, J ) 13.5, 6.2 Hz, 1H), 2.85 (dd, J ) 13.3, 1.9 Hz, 1H), 2.21-
2.15 (m, 3H), 2.10 (s, 3H), 1.68-1.63 (m, 1H), 1.61 (s, 3H), 1.03 (d,
J ) 6.8 Hz, 3H), 0.89 (s, 9H), 0.87 (d, J ) 7.0 Hz, 3H), 0.85 (d, J )
6.8 Hz, 3H), 0.80 (d, J ) 7.0 Hz, 3H), 0.03 (s, 6H); 13C NMR (100
MHz, CDCl3) δ 171.1, 170.8, 136.4, 126.4, 80.4, 77.9, 76.5, 73.3, 39.8,
36.3, 35.9, 32.7, 32.2, 28.3, 25.9, 24.2, 21.5, 21.0, 18.7, 17.2, 11.1,
9
2206 J. AM. CHEM. SOC. VOL. 126, NO. 7, 2004